← Back to Clinical Trials
Recruiting NCT07725315

NCT07725315 Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain Stimulation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07725315
Status Recruiting
Phase —
Sponsor University of Alabama at Birmingham
Condition Deep Brain Stimulation
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2026-08-01
Primary Completion 2027-11-01

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
DBS as part of standard of care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2026-08-01 with a primary completion date of 2027-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this pilot study is to assess changes in thinking and movement after deep brain stimulator implantation. The study will also examine whether these changes are related to the risk of falls.

Eligibility Criteria

Inclusion Criteria: * Age between 30-80, patient has elected to undergo DBS surgery as part of routine care, cleared for deep brain stimulation surgery as part of routine care by the movement disorders committee. Refractory motor symptoms such as dyskinesias, wearing off, and/or motor fluctuations, causing significant disability, despite reasonable attempts at medical management, as determined by the consensus DBS committee, able to walk, Patient is available for follow-up over the length of the study Exclusion Criteria: Patient's insurance will not cover the costs of surgery with investigational devices, Medical contraindications such as current uncontrolled hypertension, heart disease, coagulopathy, or other conditions contraindicating DBS surgery or stimulation, self-report of lack of clear levodopa response, requires a walker or wheelchair for mobility \-

Contact & Investigator

Central Contact

Christopher Hurt, PhD

✉ cphurt@uab.edu

📞 2059345817

Frequently Asked Questions

Who can join the NCT07725315 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 80 Years, studying Deep Brain Stimulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07725315 currently recruiting?

Yes, NCT07725315 is actively recruiting participants. Contact the research team at cphurt@uab.edu for enrollment information.

Where is the NCT07725315 trial being conducted?

This trial is being conducted at Homewood, United States.

Who is sponsoring the NCT07725315 clinical trial?

NCT07725315 is sponsored by University of Alabama at Birmingham. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology